Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease

被引：34
|
作者：
Hirten, Robert [1 ]
Longman, Randy S. [2 ]
Bosworth, Brian P. [2 ]
Steinlauf, Adam [2 ]
Scherl, Ellen [2 ]
机构：
[1] North Shore Long Isl Jewish Hlth Syst, Hofstra North Shore LIJ Sch Med, Div Gastroenterol, New Hyde Pk, NY USA
[2] Jill Roberts Ctr Inflammatory Bowel Dis, New York, NY 10021 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷 / 12期
关键词：
RANDOMIZED-TRIAL; INDUCTION;
D O I：
10.1038/ajg.2015.355
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1737 / 1738
页数：3
相关论文
共 50 条
  • [21] Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
    Cosnes, J.
    Sokol, H.
    Bourrier, A.
    Nion-Larmurier, I.
    Wisniewski, A.
    Landman, C.
    Marteau, P.
    Beaugerie, L.
    Perez, K.
    Seksik, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (10) : 1102 - 1113
  • [22] VEDOLIZUMAB TREATMENT IN CROHN'S DISEASE OF THE POUCH
    Khan, Freeha
    Singh, Amandeep
    Hull, Tracy L.
    Shen, Bo
    GASTROENTEROLOGY, 2018, 154 (06) : S591 - S592
  • [23] Vedolizumab in the treatment of Crohn's disease of the pouch
    Khan, Freeha
    Gao, Xian-Hua
    Singh, Amandeep
    Philpott, Jessica R.
    Shen, Bo
    GASTROENTEROLOGY REPORT, 2018, 6 (03): : 184 - 188
  • [24] Treatment of Crohn's disease with infliximab
    Garnett, WR
    Yunker, N
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (04) : 307 - 316
  • [25] Infliximab treatment for Crohn's disease
    Conroy, CA
    Cattell, R
    POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (909) : 436 - 440
  • [26] Combination Therapy With Infliximab and Methotrexate Does Not Improve Crohn's Disease Outcome and Infliximab Tolerance Compared to Infliximab Therapy Alone
    de Chambrun, Guillaume Pineton
    Libier, Louise
    Collins, Michael
    Nachury, Maria
    Gower-Rousseau, Corinne
    Zerbib, Philippe
    Cortot, Antoine
    Colombel, Jean-Frederic
    Desreumaux, Pierre
    Blanc, Pierre
    GASTROENTEROLOGY, 2016, 150 (04) : S811 - S811
  • [27] Combination Therapy with Infliximab and Thiopurine Compared to Infliximab Monotherapy in Maintaining Remission of Postoperative Crohn's Disease
    Sakuraba, Atsushi
    Okamoto, Susumu
    Matsuoka, Katsuyoshi
    Sato, Toshiro
    Naganuma, Makoto
    Hisamatsu, Tadakazu
    Iwao, Yasushi
    Ogata, Haruhiko
    Kanai, Takanori
    Hibi, Toshifumi
    DIGESTION, 2015, 91 (03) : 233 - 238
  • [28] Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease
    Huff-Hardy, Kayci
    Bedair, Mai
    Vazquez, Rebecca
    Burstein, Ezra
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : E49 - E49
  • [29] Infliximab in combination with immunomodulators in the treatment of children with Crohn's disease: Advantages and risks
    Veereman, Gigi
    Prytula, Agnieszka
    Mahler, Tania
    Alliet, Philippe
    Paquot, Isabelle
    GASTROENTEROLOGY, 2008, 134 (04) : A668 - A668
  • [30] Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
    Christensen, B.
    Sparrow, M. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (01) : 178 - 179
12345